Notice of Intent to Award a Sole Source Commercial Simplified Acquisition Procedures (SAP) Contract for Development of a Human Neural Network Formation New Approach Method for the Evaluation of Potential Developmental Neurotoxicity
HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Place of performance: Framingham, MA
Free. Verify your email, then we send one reminder only.
- Posted
- Jul 6, 2026
- Closes
- No deadline published by the funder
Similar opportunities open now
- Notice of Intent to Award a Sole Source Commercial Simplified Acquisition Procedures (SAP) Purchase Order for Supply Chain Monitoring – Infant FormulaSame funderOpenHEALTH AND HUMAN SERVICES, DEPARTMENT OFNo deadline listed
- Development of White Matter Atlases for the Baltimore Longitudinal Study of AgingOpenU.S. General Services Administration (SAM.gov)No deadline listed
- Notice of Intent to Award Sole Source - Home-cage Electrophysiology Recording EquipmentSame funderOpenHEALTH AND HUMAN SERVICES, DEPARTMENT OFNo deadline listed
- 3D Medical Applications Center - Notice of Intent to Sole SourceOpenDEPT OF DEFENSECloses in 37 days
- Notice of Intent to Award a Sole Source Contract – Sequencing Bundibugyo virus disease (BDBV) in the 2026 outbreakSame funderOpenHEALTH AND HUMAN SERVICES, DEPARTMENT OFNo deadline listed
At a glance
This is a government contract opportunity posted by HEALTH AND HUMAN SERVICES, DEPARTMENT OF in the other scientific and technical consulting services category. Work is performed in Framingham, MA.
Classification and identifiers
- Industry (NAICS)
- Other Scientific and Technical Consulting Services (541690)
- Product or service (PSC)
- Other Special Studies and Analysis (B599)
- Solicitation number
- HFP-2026-134390
- Contracting office
- FDA OFFICE OF ACQ GRANT SVCS
Who can apply
No Set aside used. NONE
About this opportunity
The Food and Drug Administration (FDA) intends to award a Sole Source firm-fixed price contract to Cyprotex US, LLC, 200 Staples Drive, Framingham, MA 01702, USA, incorporated for the purchase of Development of a Human Neural Network Formation New Approach Method for the Evaluation of Potential Developmental Neurotoxicity, in accordance with the authority under FAR Part 6.302-1. Only one responsible source and no other supplies or services will satisfy agency requirements. Cyprotex US, LLC is qualified for DT/OCT/OLOAS/HFP unique requirement because they are the only vendor that offers a neural network formation NAM which utilizes microelectrode array (MEA) technology that can be appropriately adapted for the agency specific needs. This acquisition is being conducted using simplified acqui...
Related opportunities
- Notice of Intent to Award a Sole Source Commercial Simplified Acquisition Procedures (SAP) Purchase Order for Supply Chain Monitoring – Infant FormulaSame funderHEALTH AND HUMAN SERVICES, DEPARTMENT OF
- Development of White Matter Atlases for the Baltimore Longitudinal Study of AgingU.S. General Services Administration (SAM.gov)
- Notice of Intent to Award Sole Source - Home-cage Electrophysiology Recording EquipmentSame funderHEALTH AND HUMAN SERVICES, DEPARTMENT OF
- 3D Medical Applications Center - Notice of Intent to Sole SourceDEPT OF DEFENSECloses in 37 days
- Notice of Intent to Award a Sole Source Contract – Sequencing Bundibugyo virus disease (BDBV) in the 2026 outbreakSame funderHEALTH AND HUMAN SERVICES, DEPARTMENT OF